DPG Mitgliedschaft

This block is broken or missing. You may be missing content or you might need to enable the original module.

Keyword: Merck & Co.

News

UK’s MHRA Approves Merck & Co Covid Pill

05.11.2021 -

The UK has “pipped the US at the post”, as one commentator noted in typical British colloquialism on the news that the country’s health regulator MHRA has approved the...

News

EMA Begins Rolling Review of Molnupiravir

26.10.2021 -

The European Medicines Agency (EMA) has begun a rolling review of US Merck & Co’s oral antiviral molnupiravir as a candidate to treat Covid-19. The EU drugs regulator...

News

Merck & Co.’s $11.5 Billion Acceleron Deal May Face Hurdles

04.10.2021 -

US drugs giant Merck & Co. has signed a definitive agreement to acquire publicly traded US biotech Acceleron Pharma for $180 per share, yielding a total equity value of...

News

US to Invest $3 Billion in Pandemic Stockpile

22.06.2021 -

In conjunction with its American Rescue Plan, the administration of US president Joe Biden has announced its intention to spend $3 billion on building a stockpile of...

News

Drugs and Maybe Covid Vaccines Headed to India

28.04.2021 -

As India’s Covid-19 infections soar and the death toll nears 200,000, wealthier countries – including the US, UK, Germany, France and Australia – are rushing supplies of...

News

Vaccine Makers Pledge Caution on Covid Rollout

09.09.2020 -

With some potential Covid-19 vaccine makers suggesting they could have a candidate ready for approval and maybe even deployment this autumn, concerns are arising that a...

News

Merck & Co Agrees Cancer Collaborations

17.07.2020 -

US pharma giant Merck & Co is boosting its cancer drug development, adding two more collaborations – with Foghorn Therapeutics and Zymeworks.

News

Germany again Wins Merck & Merck Lawsuit

03.06.2020 - In the latest round of the trademark battle between Merck & Co of the US (known outside North America as MSD) and Germany’s Merck KGaA (which trades in North America as EMD), the...

Ehrenamtliches Engagement

This block is broken or missing. You may be missing content or you might need to enable the original module.

Social Media

LinkedIn | Twitter

Subscribe to our Newsletter!

Newsletter

We keep you posted - Subscribe to the CHEManager International newsletter here!

Social Media

LinkedIn | Twitter

Subscribe to our Newsletter!

Newsletter

We keep you posted - Subscribe to the CHEManager International newsletter here!